JPH06345633A - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JPH06345633A
JPH06345633A JP13772893A JP13772893A JPH06345633A JP H06345633 A JPH06345633 A JP H06345633A JP 13772893 A JP13772893 A JP 13772893A JP 13772893 A JP13772893 A JP 13772893A JP H06345633 A JPH06345633 A JP H06345633A
Authority
JP
Japan
Prior art keywords
skin
water
external preparation
polyoxyethylene
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13772893A
Other languages
Japanese (ja)
Inventor
Hidetaka Iwai
秀隆 岩井
Junichi Fukazawa
純一 深澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP13772893A priority Critical patent/JPH06345633A/en
Publication of JPH06345633A publication Critical patent/JPH06345633A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain an external preparation for skin comprising an amphiphatic lipid orientated in a liquid crystal state, having stability and high skin care effect. CONSTITUTION:An external preparation for skin comprises (A) an amphiphatic lipid such as higher alcohol, fatty acid, ceramide, glycoceramide, phospholipid, glycolipid, cholesterol, cholesterol fatty acid ester, especially an amide derivative of the formula (R<1> is 10-26C saturated or unsaturated hydrocarbon group; R<2> is 9-25C saturated or unsaturated hydrocarbon group), (B) a nonionic surfactant, preferably a polyoxyethylene hardened castor oil or a polyoxyethylene alkyl ether having preferably 8-20 HLB value, (C) an ionic surfactant, (D) an oil agent such as hydrocarbons or animal or vegetable fats and oils and (E) an aqueous medium such as water or a combination of water and a water-soluble alcohol at a ratio of A+B+C=1-90wt.%, preferably 2-40wt.%, A:(B+C)=1:20-10:1, preferably 1:3-4:1, (A+B+C):D=1:1-50:1, preferably 3:2-12:1.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、両親媒性脂質を液晶状
に配向させ、安定でしかもスキンケア効果の高い皮膚外
用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation for orienting amphipathic lipids in a liquid crystal form, which is stable and has a high skin care effect.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】荒れ
肌、乾燥肌、老化肌等においては角層の水分量が低下し
いるとされており、従来、これらの肌の外観や感触を改
善する目的で、各種の油や水溶性保湿成分を界面活性剤
により乳化させた化粧料が用いられている。これらの乳
化型化粧料は、必然的に乳化粒子の経時的な凝集が起こ
るという問題があるため、スキンケア効果を有するとと
もに安定である剤型の開発が望まれていた。
2. Description of the Related Art It is said that the water content of the stratum corneum is reduced in rough skin, dry skin, aged skin, etc., and the purpose is to improve the appearance and feel of these skins. Therefore, cosmetics in which various oils and water-soluble moisturizing ingredients are emulsified with a surfactant are used. These emulsion-type cosmetics inevitably have a problem that the emulsified particles coagulate with time. Therefore, development of a stable formulation having a skin care effect has been desired.

【0003】特に近年、油や水溶性保湿成分に代えて両
親媒性脂質、特に角質細胞間脂質を皮膚等から抽出して
用いたり(特開昭62−29508号公報,特開昭62
−120308号公報)、その化学的な構造類似体を合
成して用いる(特開昭62−228048号公報)こと
が提案されている。角質細胞間脂質とは、角質の細胞間
に見出され、層状構造を形成し、角質細胞の接着や角層
の水和に寄与しているといわれる物質である。これら両
親媒性脂質は、角質細胞間脂質も含め、室温(25℃)
で固体であり、これを外用剤等に安定に配合するには少
量のみ配合するか、系全体を高粘度化して乳化物の分離
を遅延させるしかなく、極めて安定な乳化物を得るのは
困難であった。
In particular, in recent years, amphipathic lipids, particularly keratinocyte lipids, have been extracted from the skin or the like and used in place of oil or water-soluble moisturizing components (Japanese Patent Laid-Open Nos. 62-29508 and 62-62).
-120308), and its chemical structural analogs have been proposed to be synthesized and used (JP-A-62-228048). Keratinocyte intercellular lipid is a substance that is found between cells of the horny cell, forms a layered structure, and is said to contribute to keratinocyte adhesion and hydration of the horny layer. These amphipathic lipids, including keratinocyte lipids, are at room temperature (25 ° C)
However, it is difficult to obtain an extremely stable emulsion because it is a solid and it must be added in a small amount to stably mix it with an external preparation, or the viscosity of the entire system must be increased to delay the separation of the emulsion. Met.

【0004】従って、安定な剤型でしかもスキンケア効
果の高い皮膚外用剤が望まれていた。
Therefore, a skin external preparation having a stable dosage form and a high skin care effect has been desired.

【0005】[0005]

【課題を解決するための手段】かかる実情において、本
発明者らは鋭意研究を行った結果、両親媒性脂質と、非
イオン性界面活性剤、イオン性界面活性剤及び油剤を特
定の割合で用いれば、両親媒性脂質を液晶状に配向さ
せ、安定でしかもスキンケア効果の高い皮膚外用剤が得
られることを見出し、本発明を完成した。
Under the circumstances, as a result of intensive studies by the present inventors, as a result, the amphipathic lipid, the nonionic surfactant, the ionic surfactant and the oil agent were mixed in a specific ratio. The present invention has been completed by discovering that, when used, an amphipathic lipid can be aligned in a liquid crystal form, and a stable external preparation for skin can be obtained.

【0006】すなわち、本発明は、次の成分(A)〜
(E): (A)両親媒性脂質 (B)非イオン性界面活性剤 (C)イオン性界面活性剤 (D)油剤 (E)水性媒体 を含有し、(A)+(B)+(C)=1〜90重量%、
(A):〔(B)+(C)〕=1:20〜10:1、か
つ〔(A)+(B)+(C)〕:(D)=1:1〜5
0:1である皮膚外用剤を提供するものである。
That is, the present invention provides the following components (A) to
(E): (A) Amphipathic lipid (B) Nonionic surfactant (C) Ionic surfactant (D) Oil agent (E) Aqueous medium is contained, (A) + (B) + ( C) = 1 to 90% by weight,
(A): [(B) + (C)] = 1:20 to 10: 1, and [(A) + (B) + (C)] :( D) = 1: 1 to 5
The present invention provides a skin external preparation having a ratio of 0: 1.

【0007】本発明で用いられる(A)成分の両親媒性
脂質とは、親水部と疎水部とを併せ持ち、水には溶解し
ないが分散する傾向のある室温(25℃)で固形の物質
であり、例えば高級アルコール、脂肪酸、セラミド、糖
セラミド、リン脂質、糖脂質、コレステロール、コレス
テロール脂肪酸エステル及びこれらの構造類似体が挙げ
られる。特に好ましい両親媒性脂質としては、例えば次
の一般式(1)で表わされるアミド誘導体が挙げられ
る。
The amphipathic lipid as the component (A) used in the present invention is a substance which has both a hydrophilic part and a hydrophobic part and is insoluble in water but solid at room temperature (25 ° C.) which tends to disperse. There are, for example, higher alcohols, fatty acids, ceramides, sugar ceramides, phospholipids, glycolipids, cholesterol, cholesterol fatty acid esters and structural analogs thereof. Particularly preferred amphipathic lipids include, for example, amide derivatives represented by the following general formula (1).

【0008】[0008]

【化1】 [Chemical 1]

【0009】(式中、R1 は炭素数10〜26の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基を、R2 は炭素
数9〜25の直鎖又は分岐鎖の飽和又は不飽和の炭化水
素基を示す。)
[0009] (wherein, R 1 is a linear or branched, saturated or unsaturated hydrocarbon group of 10-26 carbon atoms, R 2 is a saturated straight chain or branched chain of 9 to 25 carbon atoms or an Indicates a saturated hydrocarbon group.)

【0010】上記アミド誘導体(1)は、例えば特開昭
62−228048号公報、特開昭63−216852
号公報等に従って製造することができる。これらの両親
媒性脂質は単独で、又は二種以上を組み合わせて使用す
ることができるが、アミド誘導体(1)を単独で、又は
これと他の両親媒性脂質とを組み合わせて用いるのが特
に好ましい。アミド誘導体(1)と他の両親媒性脂質と
を組み合わせて用いる場合、両者の比は100/1〜1
/100、特に10/1〜1/10の範囲が好ましい。
The above amide derivative (1) can be obtained, for example, from JP-A-62-128048 and JP-A-63-216852.
It can be manufactured according to the publication. These amphipathic lipids can be used alone or in combination of two or more, and it is particularly preferable to use the amide derivative (1) alone or in combination with other amphipathic lipids. preferable. When the amide derivative (1) is used in combination with another amphipathic lipid, the ratio of the two is 100/1 to 1
/ 100, particularly preferably in the range of 10/1 to 1/10.

【0011】(A)成分の両親媒性脂質は、全組成中に
0.1〜30重量%(以下、単に%で示す)、特に1〜
20%配合するのが好ましい。
The amount of the amphipathic lipid as the component (A) is 0.1 to 30% by weight (hereinafter simply referred to as%) in the total composition, and particularly 1 to
It is preferable to add 20%.

【0012】(B)成分の非イオン性界面活性剤として
は、例えばポリオキシエチレン硬化ヒマシ油;ポリオキ
シエチレンソルビタンモノステアレート、ポリオキシエ
チレンソルビタンテトラオレエート等のポリオキシエチ
レンソルビタン脂肪酸エステル;ポリオキシエチレング
リセリルモノイソステアレート、ポリオキシエチレング
リセリルトリイソステアレート等のポリオキシエチレン
グリセリル脂肪酸エステル;ポリエチレングリコールモ
ノイソステアレート等のポリエチレングリコールの脂肪
酸エステル;ポリオキシエチレンヘキシルデシルエーテ
ル、ポリオキシエチレンオクチルドデシルエーテル、ポ
リオキシエチレンラウリルエーテル、ポリオキシエチレ
ンセチルエーテル、ポリオキシエチレンステアリルエー
テル、ポリオキシエチレンオレイルエーテル、ポリオキ
シエチレンノニルフェニルエーテル等のポリオキシエチ
レンアルキルエーテルなどのポリオキシエチレン付加型
界面活性剤の他、ポリグリセリンアルキルエーテル、ポ
リグリセリン脂肪酸エステル、ショ糖脂肪酸エステル等
が挙げられるが、中でもポリオキシエチレン硬化ヒマシ
油又はポリオキシエチレンアルキルエーテルであって、
HLB値8〜20、特に10〜16のものが好ましい。
Examples of the nonionic surfactant as the component (B) include polyoxyethylene hydrogenated castor oil; polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan tetraoleate, and other polyoxyethylene sorbitan fatty acid esters; poly. Polyoxyethylene glyceryl fatty acid esters such as oxyethylene glyceryl monoisostearate and polyoxyethylene glyceryl triisostearate; Polyethylene glycol fatty acid esters such as polyethylene glycol monoisostearate; Polyoxyethylene hexyl decyl ether, polyoxyethylene octyl Dodecyl ether, polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, polyoxy Other than polyoxyethylene addition type surfactants such as polyoxyethylene alkyl ethers such as tylene oleyl ether and polyoxyethylene nonyl phenyl ether, polyglycerin alkyl ethers, polyglycerin fatty acid esters, sucrose fatty acid esters and the like, Among them, polyoxyethylene hydrogenated castor oil or polyoxyethylene alkyl ether,
An HLB value of 8 to 20, particularly 10 to 16 is preferable.

【0013】これらの非イオン性界面活性剤は単独で又
は好ましいHLB値となるよう、二種以上を組み合わせ
て使用することもでき、全組成中に0.05〜30%、
特に0.1〜10%配合するのが好ましい。
These nonionic surfactants may be used alone or in combination of two or more so as to obtain a preferable HLB value. 0.05 to 30% in the total composition,
It is particularly preferable to add 0.1 to 10%.

【0014】(C)成分のイオン性界面活性剤として
は、アニオン性界面活性剤、両性界面活性剤及びカチオ
ン性界面活性剤のいずれでもよく、アニオン性界面活性
剤としては、例えばポリオキシエチレンラウリルエーテ
ル硫酸ナトリウム、ポリオキシエチレンラウリルエーテ
ル硫酸トリエタノールアミン等のポリオキシエチレンア
ルキル硫酸塩系;ラウロイルサルコシンナトリウム、ラ
ウロイルメチルアラニンナトリウム等のN−アシルアミ
ノ酸塩系;ポリオキシエチレンラウリルエーテルリン酸
ナトリウム、ポリオキシエチレンセチルエーテルリン酸
ナトリウム、ジポリオキシエチレンアルキルエーテルリ
ン酸、トリポリオキシエチレンアルキルエーテルリン
酸、ジポリオキシエチレンノニルフェニルエーテルリン
酸、ポリオキシエチレンラウリルエーテルリン酸ナトリ
ウム、ジポリオキシエチレンラウリルエーテルリン酸ナ
トリウム等のポリオキシエチレンアルキルエーテルリン
酸塩系などが:両性界面活性剤としては、例えばアルキ
ルベタイン、アルキルアミドベタイン、アルキルスルホ
ベタインなどが:カチオン性界面活性剤としては、例え
ばジ長鎖アルキル四級アンモニウム塩、モノ長鎖アルキ
ル四級アンモニウム塩、ジ長鎖アルキルポリオキシエチ
レン四級アンモニウム塩、モノ長鎖アルキルポリオキシ
エチレン四級アンモニウム塩、ビス(ヒドロキシアルキ
ル)四級アンモニウム塩、アミド/エステル結合を有す
る四級アンモニウム塩などが挙げられる。
The ionic surfactant as the component (C) may be any of an anionic surfactant, an amphoteric surfactant and a cationic surfactant. Examples of the anionic surfactant include polyoxyethylene lauryl. Polyoxyethylene alkyl sulfates such as sodium ether sulfate and polyoxyethylene lauryl ether sulfate triethanolamine; N-acyl amino acid salts such as sodium lauroyl sarcosine and sodium lauroyl methylalanine; sodium polyoxyethylene lauryl ether phosphate, poly Sodium oxyethylene cetyl ether phosphate, dipolyoxyethylene alkyl ether phosphoric acid, tripolyoxyethylene alkyl ether phosphoric acid, dipolyoxyethylene nonylphenyl ether phosphoric acid, polyoxyethylene Polyoxyethylene alkyl ether phosphates such as sodium lauryl ether phosphate, sodium dipolyoxyethylene lauryl ether phosphate, etc .: Examples of the amphoteric surfactant include alkyl betaine, alkylamido betaine, alkyl sulfobetaine, etc .: Examples of the cationic surfactant include di long-chain alkyl quaternary ammonium salt, mono long-chain alkyl quaternary ammonium salt, di long-chain alkyl polyoxyethylene quaternary ammonium salt, mono long-chain alkyl polyoxyethylene quaternary ammonium salt. , Bis (hydroxyalkyl) quaternary ammonium salts, quaternary ammonium salts having an amide / ester bond, and the like.

【0015】これらのイオン性界面活性剤は、単独で、
又は二種以上を組み合わせて使用することができ、
(B)成分の1〜50%、特に2〜30%配合するのが
好ましい。
These ionic surfactants alone are
Or it can be used in combination of two or more,
It is preferable to add 1 to 50%, especially 2 to 30% of the component (B).

【0016】(D)成分の油剤としては、室温(25
℃)で液体であるものが好ましく、例えばスクワラン、
流動パラフィン等の炭化水素類、オリーブ油、ホホバ油
等の動植物油脂、オキシステアリン酸オクチル等の高級
アルコール高級脂肪酸エステル類等が挙げられる。これ
らの油剤は、単独で、又は二種以上を組み合わせて用い
ることができ、全組成中に0.1〜30%、特に0.5
〜20%配合するのが好ましい。
As the oil agent of the component (D), room temperature (25
Those which are liquid at (° C.) are preferred, for example squalane,
Hydrocarbons such as liquid paraffin, animal and vegetable oils and fats such as olive oil and jojoba oil, and higher alcohol higher fatty acid esters such as octyl oxystearate. These oil agents can be used alone or in combination of two or more kinds, and are 0.1 to 30%, particularly 0.5 to 30% in the total composition.
It is preferable to mix it up to 20%.

【0017】(E)成分の水性媒体としては、水、ある
いは水とエタノール、グリセリン、ソルビトール、プロ
ピレングリコール、ジプロピレングリコール、1,3−
ブタンジオール等の水溶性アルコール類との組み合わせ
が挙げられる。(E)成分は全組成中に合計で40〜9
9%、特に70〜90%配合するのが好ましい。
As the aqueous medium of the component (E), water or water and ethanol, glycerin, sorbitol, propylene glycol, dipropylene glycol, 1,3-
Examples include combinations with water-soluble alcohols such as butanediol. The total amount of the component (E) is 40 to 9 in the entire composition.
It is preferable to add 9%, particularly 70 to 90%.

【0018】本発明においては、(A)、(B)及び
(C)成分の配合量の合計が1〜90%、好ましくは2
〜40%であることが必要である。また、(A):
〔(B)+(C)〕=1:20〜10:1、好ましくは
1:3〜4:1であることが必要である。
In the present invention, the total content of the components (A), (B) and (C) is 1 to 90%, preferably 2%.
It is necessary to be ˜40%. Also, (A):
[(B) + (C)] = 1:20 to 10: 1, preferably 1: 3 to 4: 1.

【0019】さらに、〔(A)+(B)+(C)〕:
(D)=1:1〜50:1、好ましくは3:2〜12:
1であることが必要である。
Further, [(A) + (B) + (C)]:
(D) = 1: 1 to 50: 1, preferably 3: 2 to 12:
Must be 1.

【0020】本発明の皮膚外用剤においては、前記必須
成分以外に、通常の皮膚外用剤に配合される成分、例え
ばポリオール類、水溶性高分子、紫外線吸収剤、防腐
剤、香料、エタノール、無機又は有機粉体、殺菌剤、色
素等を、本発明の効果を損わない範囲で適宜配合するこ
とができる。
In the external preparation for skin of the present invention, in addition to the above-mentioned essential components, other components to be added to ordinary external preparations for skin, such as polyols, water-soluble polymers, ultraviolet absorbers, preservatives, fragrances, ethanol and inorganics. Alternatively, an organic powder, a bactericidal agent, a pigment, etc. can be appropriately added within a range that does not impair the effects of the present invention.

【0021】本発明の皮膚外用剤は、例えば(A)成分
の両親媒性脂質、(B)及び(C)成分の界面活性剤並
びに(D)成分の油剤を高温(60〜95℃)で溶解
し、これに別途混合した水相を滴下し、これを室温まで
冷却することにより製造することができる。ここで、脂
質・活性剤・油剤相にグリセリン等のポリオール類を加
えておくと、より効果的に液晶を形成させることができ
る。
The external preparation for skin of the present invention comprises, for example, an amphipathic lipid as a component (A), a surfactant as a component (B) and a component (C), and an oil agent as a component (D) at high temperature (60 to 95 ° C.). It can be manufactured by dissolving, dropping an aqueous phase separately mixed therein, and cooling it to room temperature. Here, when a polyol such as glycerin is added to the lipid / activator / oil phase, liquid crystal can be formed more effectively.

【0022】このようにして得られる本発明の皮膚外用
剤は、脂質が液晶状態をとり、その層間に水層をサンド
イッチした構造を有する。このような液晶構造は、偏光
下での顕微鏡観察によりその層状構造を確認することが
でき、またX線分析による確認も可能である。
The skin external preparation of the present invention thus obtained has a structure in which the lipid is in a liquid crystal state and a water layer is sandwiched between the layers. Such a liquid crystal structure can be confirmed for its layered structure by microscopic observation under polarized light, and also by X-ray analysis.

【0023】また、本発明の皮膚外用剤は必須成分の含
有量等を適宜選択することにより、透明な外観を有する
ものとして得られ、これにラテックス等の濁り剤を入れ
て不透明化したり、エチレングリコールエステル等を配
合してパール化したり、粉体等の組成物に溶解しない固
体を加えて幾何学模様状に分散させたり、色素を添加す
るなどして様々な外観として用いることもできる。
Further, the external preparation for skin of the present invention can be obtained as one having a transparent appearance by appropriately selecting the contents of essential components and the like, and a turbidity agent such as latex may be added to this to make it opaque or ethylene. It can be used in various appearances by blending glycol ester or the like into pearls, adding solids that are not dissolved in a composition such as powder and dispersing them in a geometric pattern, or adding a dye.

【0024】[0024]

【実施例】次に、実施例を挙げて本発明をさらに説明す
るが、本発明はこれら実施例に限定されるものではな
い。
EXAMPLES Next, the present invention will be further described with reference to examples, but the present invention is not limited to these examples.

【0025】実施例1 表1〜3に示す組成の皮膚外用剤を製造した。すなわ
ち、水以外の成分を85〜90℃に混合・溶解し、これ
に同温度に加温した水を滴下し、室温まで冷却してクリ
ームを得た。これらのクリームは、全て光学異方性をも
つ液晶であった。
Example 1 External skin preparations having the compositions shown in Tables 1 to 3 were produced. That is, components other than water were mixed and dissolved at 85 to 90 ° C., water heated to the same temperature was added dropwise thereto, and the mixture was cooled to room temperature to obtain a cream. All of these creams were liquid crystals having optical anisotropy.

【0026】[0026]

【表1】 [Table 1]

【0027】[0027]

【表2】 [Table 2]

【0028】[0028]

【表3】 [Table 3]

【0029】実施例2 表5に示す組成の皮膚外用剤を製造し、その性能を評価
した。結果を表6に示す。 (製法)水以外の成分を85〜90℃に混合、溶解し、
これに同温度に加温した水を滴下し、室温まで冷却して
クリームを得た。
Example 2 A skin external preparation having the composition shown in Table 5 was produced and its performance was evaluated. The results are shown in Table 6. (Production method) Components other than water are mixed and dissolved at 85 to 90 ° C,
Water heated to the same temperature was added dropwise to this, and cooled to room temperature to obtain a cream.

【0030】(評価方法) (1)液晶構造の確認:皮膚外用剤をガラス板上に薄く
延ばし、偏光顕微鏡で観察を行った。液晶状をとるもの
は複屈折像が認められる。複屈折像が認められたものは
○、認められないものは×で示した。 (2)皮膚コンダクタンス:冬期に頬部に肌あれを起こ
している20〜50才の女性10名を被験者とし、左右
の頬に異なるサンプルを毎日1回2週間塗布する。2週
間の塗布が終了した翌日、37℃の温水にて洗顔後、温
度20℃、湿度40%の部屋で20分間安静にした後、
角質層の水分含有量を皮膚コンダクタンスメーター(I
BS社製)にて測定した。コンダクタンス値は小さいほ
ど皮膚は肌あれし、5以下ではひどい肌あれである。一
方この値が20以上であれば肌あれはほとんど認められ
ない。 (3)肌あれスコア:皮膚コンダクタンスの場合と同様
にサンプルを2週間塗布した後、肌あれを肉眼で観察
し、下記基準により判定した。スコアは平均値±標準偏
差で示した。
(Evaluation method) (1) Confirmation of liquid crystal structure: A skin external preparation was thinly spread on a glass plate and observed with a polarizing microscope. A birefringent image is recognized in the liquid crystal form. The one in which the birefringence image was observed is indicated by ◯, and the one in which it was not observed was indicated by x. (2) Skin conductance: Ten females aged 20 to 50 who have rough skin on the cheeks in winter are used as test subjects, and different samples are applied to the left and right cheeks once a day for 2 weeks. The day after the application for 2 weeks, after washing the face with warm water of 37 ° C and resting for 20 minutes in a room at a temperature of 20 ° C and a humidity of 40%,
The water content of the stratum corneum is measured by the skin conductance meter (I
(Manufactured by BS). The smaller the conductance value is, the rougher the skin is, and when it is 5 or less, the skin is severely rough. On the other hand, if this value is 20 or more, almost no skin roughness is observed. (3) Skin roughness score: After applying the sample for 2 weeks as in the case of skin conductance, the skin roughness was visually observed and judged according to the following criteria. Scores are shown as mean value ± standard deviation.

【0031】[0031]

【表4】 [Table 4]

【0032】(4)皮膚表面での持続性:20〜50代
の女性10名を被験者とし、洗顔後、左右の頬の同一位
置、同面積に同量の皮膚外用剤を塗布する。8時間日常
生活を過ごした後、塗布部に広がった皮膚外用剤の面積
を写しとり、塗布面積に対する広がった面積比を算出し
た。
(4) Persistence on the skin surface: Ten women in their 20s to 50s were used as test subjects, and after washing the face, the same amount of the external preparation for skin was applied to the same position and the same area on the left and right cheeks. After spending daily life for 8 hours, the area of the external preparation for skin spread on the applied part was copied, and the ratio of the expanded area to the applied area was calculated.

【0033】[0033]

【表5】 [Table 5]

【0034】[0034]

【表6】 [Table 6]

【0035】[0035]

【発明の効果】本発明の皮膚外用剤は、安定な一相系の
ものである。そして、脂質が液晶状態をとり、その層間
に水層をサンドイッチした構造を有するため、組成物か
らの水分蒸散が抑制され、乳化物等に比べ含水能が高
い。従って、保湿性が高く、皮膚に水分を効率良く補給
することができ、皮膚を柔軟化させることができる。ま
た、従来の乳化物のような水相又は油相の連続相がない
ため、乳化物の凝集等が起こらず、安定な構造を保つこ
とができるので、汗等の水分や皮脂等の油に対し、皮膚
において高い持続性を有する。さらに、組成物が有する
ラメラ構造は、角質細胞間脂質が有するラメラ構造と同
じ集合構造であるため、両親媒性脂質の皮膚吸収性に優
れたものである。
The external preparation for skin of the present invention is a stable one-phase system. Further, since the lipid is in a liquid crystal state and has a structure in which an aqueous layer is sandwiched between the layers, water evaporation from the composition is suppressed and the water content is higher than that of an emulsion or the like. Therefore, the moisturizing property is high, the skin can be efficiently replenished with water, and the skin can be softened. Further, since there is no continuous phase of an aqueous phase or an oil phase like a conventional emulsion, aggregation of the emulsion does not occur and a stable structure can be maintained, so that water such as sweat and oil such as sebum can be maintained. In contrast, it has high persistence on the skin. Furthermore, since the lamellar structure of the composition is the same aggregate structure as the lamellar structure of interkeratinous lipids, it has excellent skin absorbability of amphipathic lipids.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 次の成分(A)〜(E): (A)両親媒性脂質 (B)非イオン性界面活性剤 (C)イオン性界面活性剤 (D)油剤 (E)水性媒体 を含有し、(A)+(B)+(C)=1〜90重量%、
(A):〔(B)+(C)〕=1:20〜10:1、か
つ〔(A)+(B)+(C)〕:(D)=1:1〜5
0:1である皮膚外用剤。
1. The following components (A) to (E): (A) amphipathic lipid (B) nonionic surfactant (C) ionic surfactant (D) oil agent (E) aqueous medium Contains, (A) + (B) + (C) = 1 to 90% by weight,
(A): [(B) + (C)] = 1:20 to 10: 1, and [(A) + (B) + (C)] :( D) = 1: 1 to 5
The skin external preparation is 0: 1.
JP13772893A 1993-06-08 1993-06-08 External preparation for skin Pending JPH06345633A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13772893A JPH06345633A (en) 1993-06-08 1993-06-08 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13772893A JPH06345633A (en) 1993-06-08 1993-06-08 External preparation for skin

Publications (1)

Publication Number Publication Date
JPH06345633A true JPH06345633A (en) 1994-12-20

Family

ID=15205449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13772893A Pending JPH06345633A (en) 1993-06-08 1993-06-08 External preparation for skin

Country Status (1)

Country Link
JP (1) JPH06345633A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016635A1 (en) * 1994-11-28 1996-06-06 Gist-Brocades B.V. Topical application of ceramides
EP0842655A2 (en) * 1996-11-14 1998-05-20 Kao Corporation Water-in-oil type cosmetic emulsion containing amide derivatives
EP0875232A1 (en) * 1997-05-02 1998-11-04 Takasago International Corporation A lipid composition containing liquid crystal phase
JP2001097811A (en) * 1999-09-30 2001-04-10 Shiseido Co Ltd Lipid complex and external application composition containing the complex
JP2001139796A (en) * 1999-11-12 2001-05-22 Pigeon Corp Transparent dispersion containing ceramides and method for producing the same
US6521241B1 (en) 1998-12-31 2003-02-18 Kimberly-Clark Worldwide, Inc. Substrate composition for sequestration of skin irritants
WO2009016989A1 (en) 2007-07-27 2009-02-05 Shiseido Company Ltd. Oil-in-water emulsion composition and method for producing the same
US8263058B2 (en) 2004-04-21 2012-09-11 The Procter & Gamble Company Personal care compositions that deposit hydrophilic benefit agents
KR101264902B1 (en) * 2006-03-07 2013-05-15 주식회사 엘지생활건강 Cosmetic composition in the form of liquid crystal emulsion
WO2015056807A1 (en) 2013-10-17 2015-04-23 Kao Corporation Skin cosmetic composition
US9820925B2 (en) 2014-05-30 2017-11-21 Kao Corporation Skin cosmetic
WO2022034915A1 (en) 2020-08-14 2022-02-17 花王株式会社 Method for producing film

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016635A1 (en) * 1994-11-28 1996-06-06 Gist-Brocades B.V. Topical application of ceramides
EP0842655A2 (en) * 1996-11-14 1998-05-20 Kao Corporation Water-in-oil type cosmetic emulsion containing amide derivatives
EP0842655A3 (en) * 1996-11-14 1999-01-07 Kao Corporation Water-in-oil type cosmetic emulsion containing amide derivatives
EP0875232A1 (en) * 1997-05-02 1998-11-04 Takasago International Corporation A lipid composition containing liquid crystal phase
US6521241B1 (en) 1998-12-31 2003-02-18 Kimberly-Clark Worldwide, Inc. Substrate composition for sequestration of skin irritants
JP2001097811A (en) * 1999-09-30 2001-04-10 Shiseido Co Ltd Lipid complex and external application composition containing the complex
JP2001139796A (en) * 1999-11-12 2001-05-22 Pigeon Corp Transparent dispersion containing ceramides and method for producing the same
US8263058B2 (en) 2004-04-21 2012-09-11 The Procter & Gamble Company Personal care compositions that deposit hydrophilic benefit agents
KR101264902B1 (en) * 2006-03-07 2013-05-15 주식회사 엘지생활건강 Cosmetic composition in the form of liquid crystal emulsion
WO2009016989A1 (en) 2007-07-27 2009-02-05 Shiseido Company Ltd. Oil-in-water emulsion composition and method for producing the same
WO2015056807A1 (en) 2013-10-17 2015-04-23 Kao Corporation Skin cosmetic composition
US9433567B2 (en) 2013-10-17 2016-09-06 Kao Corporation Skin cosmetic composition
US9820925B2 (en) 2014-05-30 2017-11-21 Kao Corporation Skin cosmetic
WO2022034915A1 (en) 2020-08-14 2022-02-17 花王株式会社 Method for producing film

Similar Documents

Publication Publication Date Title
JP3008212B2 (en) Transparent or translucent cosmetics
US5643600A (en) Lipid vesicles containing avocado oil unsaponifiables
JP4040527B2 (en) Lipid composition and external preparation for skin containing the same
KR100840905B1 (en) External base preparations having hexagonal gel phase
KR101052493B1 (en) Blessicle dispersions and cosmetics containing the same
EP2167015A2 (en) Dms (derma membrane structure) in foaming creams
JPS63275506A (en) Skin cosmetic
JPH06345633A (en) External preparation for skin
KR20020000212A (en) Foaming cosmetic cream
DE4205548A1 (en) BATHING AND SHOWER SUPPLEMENT WITH VESIGN-FORMING PROPERTIES, ITS MANUFACTURE AND USE
JPH04112810A (en) Aqueous cosmetic and production thereof
KR20160082054A (en) Emulsifier-Free Cosmetic Composition of the Oil-in-Water Emulsion Type and Preparation Method Thereof
JPH08283303A (en) Emulsifier comprising higher fatty acid dextrin, emulsion composition containing the same, and cosmetic
CN106606424B (en) A kind of preparation and application of the liquid crystal system containing inulin lauryl carbamate and fatty alcohol
KR20210073957A (en) Cosmetic composition for stabilizing poorly soluble materials
KR20000055082A (en) multilamellar emulsion cosmetics containing pseudoceramides
AU693488B2 (en) Lipid vesicles containing avocado oil unsaponifiables
Filipović et al. Feasibility of a natural surfactant as a stabilizer for cosmetics with liposome-encapsulated plant stem cells: pre-formulation and formulation through stability studies
JP2000072618A (en) Emulsifying agent for preparation for external use for skin
JPH0317006A (en) Cleansing base composition
Junginger Pharmaceutical emulsions and creams
KR102453278B1 (en) Rheology controllable liquid crystal emulsion composition using emulsifier mixture ratio
JPH0669532B2 (en) Oil-in-water emulsion composition
JP6046882B2 (en) Oil-in-water emulsion composition for skin
Sutton Characterization of Lamellar Liquid Crystal Emulsifiers in Topical Creams Containing a Novel Solvent